Alivo, Ruel B.

HRN: 29-11-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2026
MUPIROCIN 2%, 15G (TUBE)
06/12/2026
06/18/2026
TOPICAL
15g
BID
Infected Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: